| ID | 1106 |
|---|
| No | 1106 |
|---|
| Brand Name | DEFERASIROX GPO |
|---|
| Ingredients | DEFERASIROX 250 MG |
|---|
| Dosage Form | DISPERSIBLE TABLET |
|---|
| Primary Packaging | NYLON/ALU/PVC BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF CHRONIC IRON OVERLOAD DUE TO BLOOD TRANSFUSIONS IN ADULT AND PEDIATRIC PATIENTS (AGED 2 YEARS AND OVER). ALSO INDICATED FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA SYNDROMS AGED 10 YEARS AND OLDER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | OFF WHITE, FLATE, ROUND, COMPRESSED TABLETS, ONE SIDE DEBOSEED WITH "D250" AND THE OTHER SIDE DEBOSSED WITH "GPO" |
|---|
| Note | |
|---|
| License Owner | KARNYA VIENGNAKORN EXPORT-IMPORT |
|---|
| Manufacturer | THE GOVERNMENT PHARMACEUTICAL ORGANISATION |
|---|
| Country | THAILAND |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 I 5163/21 |
|---|
| FDD Registration Date | 10/09/2024 |
|---|
| Expiry Date | 09/09/2029 |
|---|
